1-Year outcome of TRIAS HR (TRI-stent Adjudication Study-High Risk of restenosis): A multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents

JACC: Cardiovascular Interventions

Volumn 4, Issue 8, 2011, Pages 896-904

  Klomp, Margo ^a   Beijk, Marcel A ^a   Varma, Chetan ^c   Koolen, Jacques J ^b   Teiger, Emmanuel ^d   Richardt, Gert ^e   Bea, Florian ^f   Van Geloven, Nan ^a   Verouden, Niels J ^a   Chan, Yu Kwan ^a   Woudstra, Pier ^a   Damman, Peter ^a   Tijssen, Jan G ^a   De Winter, Robbert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c CITY HOSPITAL   (United Kingdom)

^d HENRI MONDOR HOSPITAL   (France)

^e Segeberger Kliniken   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

drug eluting stent(s); endothelial progenitor cell capturing stent(s); endothelialization; restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYTOSTATIC AGENT; CYTOTOXIC AGENT; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STEM CELL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; EUROPE; FEMALE; HUMANS; HYPERPLASIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SINGLE-BLIND METHOD; STEM CELLS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860389254     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.05.011     Document Type: Article

References (35)

1. A. Colombo, J. Drzewiecki, and A. Banning Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794 (Pubitemid 37022118)
2. E. Grube, S. Silber, and K.E. Hauptmann TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42 (Pubitemid 36070930)
3. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780 (Pubitemid 34586912)
4. G.W. Stone, S.G. Ellis, and D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947 (Pubitemid 38544483)
5. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
6. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
7. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441 (Pubitemid 46717966)
8. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
9. S.H. Hofma, W.J. van der Giessen, and B.M. van Dalen Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation Eur Heart J 27 2006 166 170 (Pubitemid 43069032)
10. M. Togni, S. Windecker, and R. Cocchia Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction J Am Coll Cardiol 46 2005 231 236 (Pubitemid 40966848)
11. T. Asahara, T. Murohara, and A. Sullivan Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967 (Pubitemid 27087709)
12. T. Asahara, H. Masuda, and T. Takahashi Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221 228 (Pubitemid 29377293)
13. H.J. Duckers, T. Soullie, and P. den Heijer Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent) EuroIntervention 3 2007 350 358
14. M.J. Kutryk, and M.A. Kuliszewski In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices Am J Cardiol 92 6A 2003 94L 95L
15. M.J. Kutryk, and M.A. Kuliszewski In vivo endothelial progenitor seeding of stented arterial segments and vascular grafts (abstr) Circulation 108 Suppl IV 2003 573
16. th International Symposium on Endovascular Therapy; January 25 to 29, 2004; Miami Beach, Florida.
17. J. Aoki, P.W. Serruys, and H. van Beusekom Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry J Am Coll Cardiol 45 2005 1574 1579 (Pubitemid 40704488)
18. M. Co, E. Tay, and C.H. Lee Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up Am Heart J 155 2008 128 132 (Pubitemid 350234778)
19. H.J. Duckers, S. Silber, and R.J. de Winter Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent EuroIntervention 3 2007 67 75
20. Y.P. Lee, E. Tay, and C.H. Lee Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one year follow-up EuroIntervention 5 2010 698 702
21. M. Klomp, M.A. Beijk, N.J. Verouden, J.G. Tijssen, and R.J. de Winter Design and rationale of the TRI-stent adjudication study (TRIAS) program Am Heart J 158 2009 527 532
22. S.B. King III, S.C. Smith Jr., and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 172 209
23. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
24. K.D. Dawkins, E. Grube, and G. Guagliumi Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice Circulation 112 2005 3306 3313 (Pubitemid 43739376)
25. E. Grube, K.D. Dawkins, and G. Guagliumi TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions Eur Heart J 28 2007 2578 2582 (Pubitemid 350071532)
26. S. Silber, P. Damman, and M. Klomp Clinical results after coronary stenting with the Genous™ Bio-Engineered R Stent™: 12-month outcomes of the E-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry EuroIntervention 6 2011 819 825
27. M. Miglionico, G. Patti, A. D'Ambrosio, and G. Di Sciascio Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients Catheter Cardiovasc Interv 71 2008 600 604 (Pubitemid 351550395)
28. M.A. Beijk, M. Klomp, and N.J. Verouden Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study Eur Heart J 31 2010 1055 1064
29. G.W. Stone, S.G. Ellis, and L. Cannon Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 2005 1215 1223 (Pubitemid 41352109)
30. M.A. Turco, J.A. Ormiston, and J.J. Popma Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program J Am Coll Cardiol Intv 1 2008 699 709
31. S. Windecker, P.W. Serruys, and S. Wandel Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
32. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678 (Pubitemid 46281313)
33. J. Aoki, A.C. Abizaid, and P.W. Serruys Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients J Am Coll Cardiol 46 2005 1670 1676 (Pubitemid 41531621)
34. H.C. de Boer, M.M. Hovens, and A.M. van Oeveren-Rietdijk Human CD34+/KDR+ cells are generated from circulating CD34+ cells after immobilization on activated platelets Arterioscler Thromb Vasc Biol 31 2011 408 415
35. M. Klomp, M.A. Beijk, and J.G. Tijssen Significant intimal hyperplasia regression between 6 and 18 months following Genousendothelial progenitor cell capturing stent placement Int J Cardiol 147 2011 289 291